Suchergebnisse - "Huang, Hongbiao"

PubPharm (9)

1

Selective degradation of AR-V7 to overcome castration resistance of prostate cancer

enthalten in: Cell death & disease | 2021

von Liu, Y. | Yu, C. | Shao, Z. | +8

2

Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide

enthalten in: Journal of experimental & clinical cancer research : CR | 2019

von Xia, X. | Huang, C. | Liao, Y. | +7

3

Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling

enthalten in: European journal of pharmacology | 2019

von Liu, N. | Guo, Z. | Xia, X. | +9

4

Growth arrest and apoptosis induction in androgen receptor-positive human breast cancer cells by inhibition of USP14-mediated androgen receptor deubiquitination

enthalten in: Oncogene | 2018

von Liao, Y. | Xia, X. | Liu, N. | +8

5

Platinum-containing compound platinum pyrithione suppresses ovarian tumor proliferation through proteasome inhibition

enthalten in: Journal of experimental & clinical cancer research : CR | 2017

von Huang, H. | Liu, N. | Liao, Y. | +12

6

Repurposing an antidandruff agent to treating cancer : zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases

enthalten in: Oncotarget | 2017

von Zhao, C. | Chen, X. | Yang, C. | +15

7

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor

enthalten in: Cell death & disease | 2017

von Liao, Y. | Liu, N. | Hua, X. | +5

8

Platinum-containing compound platinum pyrithione is stronger and safer than cisplatin in cancer therapy

enthalten in: Biochemical pharmacology | 2016

von Zhao, C. | Chen, X. | Zang, D. | +15

9

Anti-rheumatic agent auranofin induced apoptosis in chronic myeloid leukemia cells resistant to imatinib through both Bcr/Abl-dependent and -independent mechanisms

enthalten in: Oncotarget | 2014

von Chen, X. | Shi, X. | Zhao, C. | +13

1
[1]